Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTROH: Low-dose Heparin in Aneurysmal Subarachnoid Hemorrhage
NCT02501434Phase 2Suspended
- Start
- Apr 2016
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin in aneurysmal subarachnoid hemorrhage (SAH). Started Apr 2016; status: suspended.
02
Drugs
heparin
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02501434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02501434.